Soligenix, Inc.
Soligenix, Inc. scores highest on Earnings (60) and lowest on Nitro (24). Its PosiPenta is 34.96 out of 100, weaker than most similar companies.
On the Penta Grid this week, Soligenix, Inc. is Grid #672 of 837 in the Healthcare sector in United States, and Grid #3,302 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Soligenix, Inc. | 34.96 | 25 | 60 | 24 | 36 | 29 |
| CalciMedica, Inc. | 27.26 | 36 | 40 | 3 | 10 | 46 |
| Bolt Biotherapeutics, Inc. | 32.77 | 44 | 11 | 52 | 19 | 38 |
| Biomerica, Inc. | 43.62 | 20 | 64 | 54 | 23 | 56 |
| Curanex Pharmaceuticals Inc | 31.33 | 33 | 10 | 30 | 33 | 51 |
| Vistagen Therapeutics, Inc. | 32.84 | 47 | 32 | 4 | 41 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.45 |
| P/B ratio | 2.49 |
EEarnings
| Trailing EPS | ₹-74.82 |
| Forward EPS | ₹-23.68 |
NNitro
| Price | 33.44 |
| 52-week high | 166.70 |
| 52-week low | 26.52 |
| Fall from 52-week high | 79.9% |
TTorque
| Return on equity (ROE) | -241.65% |
| Debt-to-equity | 0.05 |
AAnchor
| Beta (price swings) | 2.00 |
| Market cap | ₹72 Cr |
| Insider holding | 4.59% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Soligenix, Inc.'s PosiPenta score?
Soligenix, Inc.'s PosiPenta is 34.96 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Soligenix, Inc. stand on the Penta Grid?
On the Penta Grid this week, Soligenix, Inc. is Grid #672 of 837 in the Healthcare sector in United States, and Grid #3,302 of 4,000 in United States.
Which PosiPenta pillar is strongest for Soligenix, Inc.?
Earnings (growth), with a score of 60 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Soligenix, Inc.?
Nitro (momentum), with a score of 24 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.